Stay updated on Pembrolizumab in Esophageal Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.

Latest updates to the Pembrolizumab in Esophageal Ca Clinical Trial page
- Check6 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.3 was added to the page history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. These are minor site maintenance updates; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.3.2 to the history list. Removed Revision: v3.2.0 from the history list.SummaryDifference0.0%

- Check64 days agoChange DetectedThe notice about government funding and NIH operating status that was previously shown on the page has been removed. This change does not affect the trial details, eligibility, or results information.SummaryDifference0.2%

- Check78 days agoChange DetectedNo new or removed content is shown; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check107 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference6%

Stay in the know with updates to Pembrolizumab in Esophageal Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.